PHARMACIELO LTD (PCLO.CA) Stock Balance Sheet
TSX-V:PCLO - TSX Venture Exchange - CA71716K1012 - Common Stock - Currency: CAD
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | N/A | N/A | N/A | |||
| Cash Equivalents | 62.20K | 173.00K | 5.34M | 8.86M | 13.67M | |||
| Marketable Securities | N/A | 153.00K | 291.00K | 750.10K | 106.00K | |||
| Receivables | 761.10K | 670.70K | 565.20K | 924.10K | 1.82M | |||
| Inventories | 2.31M | 2.13M | 2.28M | 1.25M | 3.64M | |||
| Other Current Assets | 192.50K | 889.20K | 721.30K | 732.10K | 426.60K | |||
| Total Current Assets | 3.33M | 4.02M | 9.20M | 12.52M | 19.67M | |||
| Non-Current Assets | ||||||||
| PPE Net | 18.71M | 20.62M | 26.12M | 30.82M | 28.72M | |||
| Investments And Advances | 210.50K | 204.00K | 639.60K | 565.40K | N/A | |||
| Goodwill | N/A | N/A | N/A | 0.00 | 1.16M | |||
| Intangibles | N/A | N/A | 0.00 | 120.10K | 639.80K | |||
| Other Non-Current Assets | N/A | N/A | N/A | N/A | 0.00 | |||
| Total Non-Current Assets | 18.96M | 21.10M | 26.76M | 31.51M | 30.52M | |||
| TOTAL ASSETS | 22.29M | 25.12M | 35.96M | 44.02M | 50.20M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | 15.76M | 816.80K | 227.30K | 242.90K | 147.60K | |||
| Accounts Payable | 5.63M | 6.11M | 7.73M | 11.71M | 2.90M | |||
| Other Current Liabilities | 25.90K | 25.90K | 111.80K | 105.30K | 258.20K | |||
| Total Current Liabilities | 21.42M | 6.95M | 8.07M | 12.06M | 3.31M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 2.55M | 11.77M | 8.20M | 4.23M | 1.42M | |||
| Other Non-Current Liabilities | N/A | 0.00 | 356.40K | 1.49M | N/A | |||
| Total Non-Current Liabilities | 2.55M | 11.77M | 8.56M | 5.72M | 1.42M | |||
| TOTAL LIABILITIES | 23.97M | 18.72M | 16.63M | 17.78M | 4.73M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -163.09M | -147.19M | -132.76M | -109.81M | -71.27M | |||
| Common Shares | 166.77M | 162.27M | 158.29M | 138.64M | 116.83M | |||
| Other Shareholders' Equity | -5.36M | -8.69M | -6.21M | -2.58M | -93.60K | |||
| Shares Outstanding | 169.14M | 154.96M | 149.27M | 138.75M | 98.97M | |||
| Tangible Book Value per Share | -0.01 | 0.04 | 0.13 | 0.19 | 0.44 | |||
| Total Shareholders' Equity | -1.68M | 6.39M | 19.33M | 26.25M | 45.47M | |||
| TOTAL LIABILITIES AND EQUITY | 22.29M | 25.12M | 35.96M | 44.02M | 50.20M | |||
| Statistics | ||||||||
| Debt/Equity | -1.52 | 1.84 | 0.42 | 0.16 | 0.03 | |||
| Current Ratio | 0.16 | 0.58 | 1.14 | 1.04 | 5.95 | |||
| Return On Assets (ROA) | -73.12% | -57.80% | -74.06% | -99.39% | -69.06% | |||
| Return On Equity (ROE) | N/A | -227.10% | -137.79% | -166.71% | -76.25% | |||
All data in CAD , ROIC based on taxRate of 0.28